Documentos relacionados

1. TPMT and HLA-DQA1-HLA-DRB genetic profiling to guide the use of azathioprine in the treatment of interstitial lung disease: First experience.
2. Evaluation of Time to Onset and Outcome of Lung Adverse Events Related to Pembrolizumab Using Marketing Surveillance.
3. [Case Report of an Elderly Patient with Interstitial Pneumonia Caused by the Administration of Trastuzumab plus Anastrozole for the Treatment of Inflammatory Breast Cancer].
4. [A Case of Liver Abscess during Treatment for Abemaciclib-Induced Interstitial Lung Disease].
5. Acute hypoxic respiratory failure due to Lenalidomide-induced interstitial pneumonitis in a patient with multiple myeloma.
6. [Case of thalidomide-induced interstitial pneumonia].
7. Severe lung injury induced by CD38 monoclonal antibody Daratumumab and bortezomib-containing regimen in a patient with preexisting interstitial lung disease: a case report and literature review.
8. [Interstitial pneumonia during treatment with thalidomide in a patient with multiple myeloma].
9. [Drug-induced interstitial lung diseases].
10. Risk of drug-induced interstitial lung disease in hospitalised patients: a nested case-control study.